Definium Therapeutics, Inc. (DFTX)
NASDAQ: DFTX · Real-Time Price · USD
32.02
-0.98 (-2.97%)
Nov 13, 2026, 10:01 AM EST - Market open
Definium Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Reiterates $90 | Buy | Reiterates | $90 | +181.07% | Nov 12, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $72 | Buy | Maintains | $72 | +124.86% | Nov 11, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Nov 10, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $75 | Buy | Maintains | $75 | +134.23% | Nov 10, 2026 |
| Needham | Needham | Buy Reiterates $66 | Buy | Reiterates | $66 | +106.12% | Nov 10, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $78 | Buy | Reiterates | $78 | +143.60% | Nov 10, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $75 | Buy | Reiterates | $75 | +134.23% | Nov 10, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $91 | Buy | Reiterates | $91 | +184.20% | Nov 10, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.